UK NSC online seminar on screening effectiveness
The most recent UK NSC online seminar looked at assessing screening effectiveness, using the UK abdominal aortic aneurysm (AAA) screening programmes as a case study.
TJ Day
TJ is Senior Content Designer for the UK NSC and DHSC screening team. She has worked on information development, content design and stakeholder engagement in screening since 2004.
Sign up for UK NSC online seminar on assessing screening programme effectiveness
Posted by:
TJ Day, Posted on:
-
Categories:
Abdominal Aortic Aneurysm Screening, UK National Screening Committee
The UK NSC is holding its next seminar on 1 December, looking at how to assess the effectiveness of screening programmes.
UK NSC announces engagement event for organisations developing novel cervical screening tests
The UK National Screening Committee is hosting a roundtable information-sharing event on new technologies relating to cervical screening tests.
Feedback invited on UK NSC’s work on additional breast screening for women with dense breasts
The UK NSC is seeking feedback on evidence relating to additional breast screening for women with dense breasts.
300-plus stakeholders attend UK NSC seminar on breast screening and breast density
The recent UK NSC online seminar on breast screening and breast density attracted more than 300 attendees.
Consultation opens on newborn screening for metachromatic leukodystrophy (MLD)
The UK NSC has opened a public consultation on screening for metachromatic leukodystrophy (MLD).
Sign up for UK NSC online seminar on breast screening and breast density
The next UK NSC seminar, on the topic of breast screening and breast density, will be held on 9 June. You can register for it now.
More than 200 stakeholders attend UK NSC seminar on multi-cancer detection tests
More than 200 stakeholders attended a fascinating UK National Screening Committee (UK NSC) seminar exploring multi-cancer detection tests (MCDs) and their potential use in a screening context. Attendees included academics, clinicians, researchers, industry representatives, patient organisations, screening providers, policy makers …